Stay updated on Selpercatinib in Advanced Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Selpercatinib in Advanced Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Selpercatinib in Advanced Solid Tumors Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page's Locations section has been updated to include an expanded, global list of study sites across the United States, Canada, Australia, and various European and Asian regions, replacing the previous subset.
    Difference
    3%
    Check dated 2025-12-17T18:54:05.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    Added a note that PubMed publications shown on the page are automatically filled from PubMed and may not pertain to the study, and updated the page revision to v3.3.2; the previous PubMed note referencing v3.2.0 was removed.
    Difference
    0.0%
    Check dated 2025-11-26T13:52:33.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Removed the government funding status notice banner from the page. The notice previously warned that information may not be up to date during funding lapses, and the page now presents only the study details.
    Difference
    0.2%
    Check dated 2025-11-19T08:37:53.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    The changes are limited to non-substantive UI adjustments on the Study Details page, with no edits to core trial information (eligibility, endpoints, or enrollment). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-10-28T05:16:56.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page now shows newer date values (2025-10-20, 2027-02, 2025-10-17, 2025-10) and removes older ones (2025-06-04, 2026-02, 2025-06-03, 2025-06). This suggests an update of time-sensitive information, with no indication of changes to core content, pricing, stock, or availability.
    Difference
    0.3%
    Check dated 2025-10-21T01:41:34.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    - Added a new Auvergne-Rhône-Alpes location entry and updated address to Lyon, Auvergne-Rhône-Alpes, France 69008; increased version to v3.2.0. - Removed the Rhône-Alpes location entry and specific resource for Medullary thyroid carcinoma. - Added a government funding notice and operating status information for NIH Clinical Center with links to cc.nih.gov and opm.gov.
    Difference
    2%
    Check dated 2025-10-06T16:06:06.000Z thumbnail image

Stay in the know with updates to Selpercatinib in Advanced Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Selpercatinib in Advanced Solid Tumors Clinical Trial page.